Cytiva News

11. Cytiva Launches Xcellerex Automated Perfusion System For More Efficient Manufacture Of Biotherapeutics 9/16/2020

    Cytiva, a global life sciences leader, is introducing an innovation to the market that supports the biotech industry’s move to continuous manufacturing. Called the Xcellerex Automated Perfusion System (APS), it simplifies processes and reduces risk when intensifying upstream operations.

12. New KUBio Box For Viral Vectors Boosts Gene Therapy Manufacturing 10/28/2019

    GE Healthcare Life Sciences is launching KUBio™ box, a fully-integrated, flexible, and adaptable biomanufacturing environment to accelerate the production of viral vector-based gene therapies. The latest addition to the KUBio modular bioprocessing portfolio, KUBio box is expected to speed gene therapies to market and contribute to increased capacity in the viral vector area.

13. Karolinska University Hospital And GE Healthcare Collaborate To Advance Technologies For Cell Therapy 5/22/2012

    Karolinska University Hospital Sweden and GE Healthcare Life Sciences recently announced a joint research collaboration to drive advances in technologies and workflows for use in the rapidly emerging field of cell therapy. 

14. GE Healthcare Life Sciences Launches Capto™ L Chromatography Medium For Capture Of Antibodies And Antibody Fragments 5/8/2012

    GE Healthcare’s Capto L affinity chromatography medium (resin) is designed for the purification of antibody fragments. It combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has strong affinity for the variable region of antibody’s kappa light chain.

15. GE Healthcare And Refine Technology Sign Supply And Distribution Agreement To Support Drive For Continuous Processing In Biopharmaceutical manufacture 4/11/2012
    GE Healthcare, the healthcare business of GE has signed a worldwide supply and distribution agreement with Refine Technology, a manufacturer and supplier of novel filtration systems for use in biopharmaceutical manufacturing.
16. GE Healthcare Life Sciences launches Capto™ Core 700 Chromatography Medium For Viruses And Other Large Biomolecules 4/3/2012
    Capto Core 700 is a multimodal chromatography medium (resin) designed for intermediate purification and polishing of viruses and other large biomolecules.
17. GE Healthcare And BAC Collaborate To Launch New Bioprocess Affinity Resin 3/20/2012

    GE Healthcare, the healthcare business of GE and BAC BV, the leading provider of antibody-based affinity purification technology, announced recently that, following a successful collaboration between the two companies, GE Healthcare Life Sciences has added a new and innovative affinity resin to its portfolio of technologies for the purification of antibody-based fragments.